WELLS FARGO & COMPANY/MN - ARCA BIOPHARMA INC ownership

ARCA BIOPHARMA INC's ticker is ABIO and the CUSIP is 00211Y506. A total of 28 filers reported holding ARCA BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 1.30 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ARCA BIOPHARMA INC
ValueSharesWeighting
Q3 2023$151
-28.4%
75
-27.9%
0.00%
Q2 2023$211
+6.0%
104
+4.0%
0.00%
Q1 2023$199
-14.2%
100
+2.0%
0.00%
Q4 2022$23298
+2.1%
0.00%
Q3 2022$0960.0%0.00%
Q2 2022$096
+7.9%
0.00%
Q1 2022$089
+1.1%
0.00%
Q4 2021$0880.0%0.00%
Q3 2021$088
-42.9%
0.00%
Q2 2021$0154
+156.7%
0.00%
Q1 2021$060
-1.6%
0.00%
Q4 2020$061
+69.4%
0.00%
Q3 2020$036
+227.3%
0.00%
Q2 2020$0110.0%0.00%
Q1 2020$0110.00%
Other shareholders
ARCA BIOPHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
BML Capital Management, LLC 706,930$1,406,7911.22%
Newtyn Management, LLC 519,765$1,034,3320.20%
Murchinson Ltd. 52,800$100,6800.01%
Marquette Asset Management, LLC 17,318$34,4630.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 46,948$93,4270.00%
Tekla Capital Management LLC 32,461$64,5970.00%
OSAIC HOLDINGS, INC. 57$1130.00%
DIMENSIONAL FUND ADVISORS LP 42,502$84,5790.00%
Parallel Advisors, LLC 244$4860.00%
BANK OF AMERICA CORP /DE/ 31$620.00%
View complete list of ARCA BIOPHARMA INC shareholders